期刊
VACCINE
卷 38, 期 49, 页码 7702-7707出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2020.09.042
关键词
Brighton Collaboration; CEPI; COVID-19; Vaccine; Benefit-risk; Safety; Live; Attenuated; Viral; Template
资金
- Coalition for Epidemic Preparedness Innovations (CEPI)
Several live-attenuated viral vaccine candidates are among the COVID-19 vaccines in development. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) has prepared a standardized template to describe the key considerations for the benefit-risk assessment of live-attenuated viral vaccines. This will help key stakeholders assess potential safety issues and understand the benefit-risk of such vaccines. The standardized and structured assessment provided by the template would also help to contribute to improved communication and support public acceptance of licensed live-attenuated viral vaccines. (C) 2020 The Author(s). Published by Elsevier Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据